131 related articles for article (PubMed ID: 3033550)
1. [Neuron-specific enolase: a new marker for small-cell pulmonary carcinoma].
Rapellino M; Pecchio F; Baldi S; Obert R; Bevilacqua Rapellino A; Oliaro A; Pischedda F; Ardissone F
Minerva Med; 1987 Apr; 78(7):465-7. PubMed ID: 3033550
[TBL] [Abstract][Full Text] [Related]
2. High neuron specific enolase levels in bronchoalveolar lavage fluid of patients with lung carcinoma: diagnostic value, relation to serum neuron specific enolase, and staging.
Dowlati A; Bury T; Corhay JL; Weber T; Mendes P; Radermecker M
Cancer; 1996 May; 77(10):2039-43. PubMed ID: 8640667
[TBL] [Abstract][Full Text] [Related]
3. [A clinical study on neuron specific enolase (NSE) as a tumor marker in primary lung cancer].
Suzuki K; Reshad K; Takahashi Y; Morita H; Hirata T; Itoi K; Nakano Y
Nihon Kyobu Shikkan Gakkai Zasshi; 1987 Jun; 25(6):625-31. PubMed ID: 2824900
[No Abstract] [Full Text] [Related]
4. Immunostaining of neuron-specific enolase is a valuable aid to the cytological diagnosis of neuroendocrine tumours of the lung.
Springall DR; Lackie P; Levene MM; Marangos PJ; Polak JM
J Pathol; 1984 Aug; 143(4):259-65. PubMed ID: 6090626
[TBL] [Abstract][Full Text] [Related]
5. [Evaluation of neuron-specific enolase as a new tumor marker for carcinoma of the lung].
Ariyoshi Y
Gan No Rinsho; 1984 May; 30(6 Suppl):569-73. PubMed ID: 6086970
[TBL] [Abstract][Full Text] [Related]
6. Neuron specific enolase: a marker of (small cell) cancers of neuronal and neuroendocrine origin.
Cooper EH
Biomed Pharmacother; 1985; 39(4):165-6. PubMed ID: 2998499
[TBL] [Abstract][Full Text] [Related]
7. Cut-off levels of NSE to differentiate SCLC from NSCLC.
Satoh H; Ishikawa H; Kurishima K; Yamashita YT; Ohtsuka M; Sekizawa K
Oncol Rep; 2002; 9(3):581-3. PubMed ID: 11956631
[TBL] [Abstract][Full Text] [Related]
8. [Neuron-specific enolase in bronchial carcinoma. Immunohistochemical and immunoenzyme study].
Leonardo E; Dogliotti C; Oliaro A
Minerva Med; 1986 May; 77(22-23):977-80. PubMed ID: 3014380
[TBL] [Abstract][Full Text] [Related]
9. [Creatine kinase BB and neuron specific r-enolase as biomarkers for lung cancer].
Usui A; Fujita K; Imaizumi M; Abe T; Inoue K; Matsumoto S; Kato K
Gan No Rinsho; 1987 Nov; 33(14):1763-70. PubMed ID: 2826840
[TBL] [Abstract][Full Text] [Related]
10. Pro-gastrin-releasing peptide (ProGRP)--a useful marker in small cell lung carcinomas.
Stieber P; Dienemann H; Schalhorn A; Schmitt UM; Reinmiedl J; Hofmann K; Yamaguchi K
Anticancer Res; 1999; 19(4A):2673-8. PubMed ID: 10470218
[TBL] [Abstract][Full Text] [Related]
11. Pro-gastrin-releasing peptide (ProGRP) and neuron specific enolase (NSE) in therapy control of patients with small-cell lung cancer.
Schneider J; Philipp M; Salewski L; Velcovsky HG
Clin Lab; 2003; 49(1-2):35-42. PubMed ID: 12593474
[TBL] [Abstract][Full Text] [Related]
12. [Serum NSE (neuron-specific enolase) levels in small cell lung cancer, with special reference to the measurement of serial serum NSE levels].
Kawachi S; Shimabukuro Z; Aoyama A; Yano T; Hasegawa K; Tsuboi E; Niitani H
Gan To Kagaku Ryoho; 1987 Aug; 14(8):2469-74. PubMed ID: 3039919
[TBL] [Abstract][Full Text] [Related]
13. Doubling time of neuron-specific enolase and survival in small cell lung cancer patients. Results of a preliminary analysis.
Splinter TA; Cooper EH; Oosterom R; Peake MD; Brown DA; Kho GS
Eur J Respir Dis Suppl; 1987; 149():37-44. PubMed ID: 3034646
[TBL] [Abstract][Full Text] [Related]
14. [Clinical evaluation of serum neuron-specific enolase as a tumor marker in lung cancer].
Yonei T; Ohnoshi T; Hiraki S; Yamashita H; Ishii J; Egawa T; Kozuka A; Moritaka T; Uji H; Yoshida M
Nihon Kyobu Shikkan Gakkai Zasshi; 1988 Feb; 26(2):139-44. PubMed ID: 2841525
[No Abstract] [Full Text] [Related]
15. Cytokeratin 19 fragment CYFRA 21-1 compared with carcinoembryonic antigen, squamous cell carcinoma antigen and neuron-specific enolase in lung cancer. Results of an international multicentre study.
Ebert W; Dienemann H; Fateh-Moghadam A; Scheulen M; Konietzko N; Schleich T; Bombardieri E
Eur J Clin Chem Clin Biochem; 1994 Mar; 32(3):189-99. PubMed ID: 7518259
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of Cyfra 21-1 as a marker for lung cancer.
Najemnik C; Mohn-Staudner A; Vetter H; Kokron O; Baumgartner G; Scheiner W; Zwick H; Koderhold G; Alth G; Dudczak R
Wien Klin Wochenschr; 1996; 108(15):467-72. PubMed ID: 8806188
[TBL] [Abstract][Full Text] [Related]
17. Methodological and clinical evaluation of two automated enzymatic immunoassays as compared with a radioimmunoassay for neuron-specific enolase.
Schmitt UM; Stieber P; Hasholzner U; Pahl H; Hofmann K; Fateh-Moghadam A
Eur J Clin Chem Clin Biochem; 1996 Aug; 34(8):679-82. PubMed ID: 8877347
[TBL] [Abstract][Full Text] [Related]
18. [Determination of serum neuron-specific enolase in bronchial tumors of neuroendocrine origin].
Rapellino M; Pecchio F; Cunazza M; Baldi S; Adamo MR; Casadio C; Faga C; Baldi C; Oliaro A; Albertino B
Minerva Med; 1988 Dec; 79(12):1051-2. PubMed ID: 2850512
[TBL] [Abstract][Full Text] [Related]
19. [Neuron-specific enolase as a new tumor marker].
Ariyoshi Y; Kato K; Ishiguro Y; Ota K; Sato T; Suchi T
Gan To Kagaku Ryoho; 1983 Aug; 10(8):1744-53. PubMed ID: 6349546
[TBL] [Abstract][Full Text] [Related]
20. Potential utility of serum neuron-specific enolase levels in small cell carcinoma of the lung.
Johnson DH; Marangos PJ; Forbes JT; Hainsworth JD; Van Welch R; Hande KR; Greco FA
Cancer Res; 1984 Nov; 44(11):5409-14. PubMed ID: 6091878
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]